Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children

• Main Authors: Cressey T.R., Green H., Khoo S., Treluyer J.-M., Compagnucci A., Saidi Y., Lallemant M., Gibb D.M., Burger D.M.
• Format: Article
• Language: English
• Published: 2014
• Online Access: http://www.scopus.com/inward/record.url?eid=2-s2.0-43249121119&partnerID=40&md5=70cde227052f32d5d5b16fff84a6ff30; http://www.ncbi.nlm.nih.gov/pubmed/18419497; http://cmuir.cmu.ac.th/handle/6653943832/729
• Institution: Chiang Mai University

Background. The optimum strategy for stopping treatment with drugs that have different half-lives in a combination regimen to minimize the risk of selecting drug-resistant viruses remains unknown. We evaluated drug concentrations in plasma, human immunodeficiency virus (HIV) load, and development of...